Post your job infront of 100,000+ qualified LP's and GP's.
Recently Filled Jobs
Firms you might be interested in
A Small Group Of Scientists, Execs, And Vcs Are $277M Richer As Their Companies Race To Create A Coronavirus Vaccine. Here Are 7 Who Have Raked In Huge Sums. | Markets Insider
Posted on: Feb. 28, 2020, 9:01 a.m.
Gilead, Moderna, and Novavax have all enjoyed massive gains after announcing potential coronavirus drugs, leading their executives, scientists, and early investors to rake in millions. The profits come as global markets tank on growing coronavirus concerns. Moderna has gained the most of the three since Friday's close, jumping 60% after announcing on Monday it submitted the first coronavirus vaccine for human trials. Here are the seven shareholders to collectively profit $277 million from the surging biotech stocks. Visit the Business ... Full investment news articleRelevent to this post: Harvard Management Company ,